A Clinical Research about the Intermittent Medication Treatment on the Female Urogenital Tract Mycoplasma Infection ()
ABSTRACT
Object: To explore a
better treatment on the female urogenital tract mycoplasma infection so as to
ensure the health of female reproduction. Method: 115 female patients with
urogenital tract mycoplasma
infection are selected, including
63 patients acted as a group for intermittent medication treatment; that is to
say, the ones that are confirmed to be sensitive drugs to those 63 patients are
chosen, and let them take this medication for 15 days and stop taking it for 7
days and after that continue to take it for 10 days. The other 52 patients in
the other group which acts as a contrast to the former group are cured with a
course of conventional treatment for 15 - 21 days. Results: As to those 115
female patients with urogenital tract mycoplasma infection, 43 patients get
relapsed, and 27 patients of them are in the contrast group and 16 patients are
in the treatment group. There is
obvious difference on the contrast of relapse rate between the treatment group
and contrast group, and they are P < 0.01. But as to the sensitive testing
results of 10 common antibiotic medicines, there are cases of illness of
relapse in those 2 groups, and the rate of drug sensitivity in the treatment
group is higher than that of the contrast group. Between treatment group and
contrast group, there is obvious difference in the sensitivity of the drugs, P
< 0.05 average. Conclusion: When the female patients with urogenital tract
mycoplasma infection are cured with a traditional treatment, because of the
side effects of drugs, they are not likely to take medicines that are required
to making the cure rate become lower and the relapse rate become higher. But
intermittent medication is designed with the half-life period of medicine,
which makes the medicine can be digested and absorbed easily, and the cure rate
is high and the relapse rate is low. With this research we found a more
effective method of the treatment on the female urogenital tract mycoplasma
infection and showed the clinical significance in intermittent medication.
Share and Cite:
Su, G. , Luo, X. , Liang, R. and Pan, L. (2014) A Clinical Research about the Intermittent Medication Treatment on the Female Urogenital Tract Mycoplasma Infection.
Open Journal of Obstetrics and Gynecology,
4, 800-804. doi:
10.4236/ojog.2014.413110.
Cited by
No relevant information.